RNA

Avidity Biosciences (RNA)

Avidity Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:RNA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/22	05:05	PR Newswire (US)	Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/20	22:00	PR Newswire (US)	Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/18	05:05	PR Newswire (US)	Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/15	08:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/15	07:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/15	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/15	07:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/15	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/15	05:58	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/15	05:10	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/14	22:00	PR Newswire (US)	Avidity Biosciences to Participate in Upcoming Investor Conference	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/14	09:00	PR Newswire (US)	Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/14	05:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/13	05:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/13	05:19	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/13	05:01	PR Newswire (US)	Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/12	20:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/12	20:00	PR Newswire (US)	Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2 FORTITUDE™ Trial Demonstrating Greater Than 50 Percent Reduction in DUX4 Regulated Genes and Trends of Functional Improvement in People Living with Facioscapulohumeral Muscular Dystrophy	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/06	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/06/05	05:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/30	05:05	PR Newswire (US)	Avidity Biosciences to Present Preliminary Data from Phase 1/2 FORTITUDE™ Trial of AOC 1020 in People Living with Facioscapulohumeral Muscular Dystrophy at 31st Annual FSHD Society International Research Congress	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/22	05:05	PR Newswire (US)	Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/17	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/17	07:15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/15	22:10	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/15	22:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/15	22:00	PR Newswire (US)	Avidity Biosciences Announces Appointment of Simona Skerjanec to Board of Directors	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/10	05:22	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/10	05:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RNA	Avidity Biosciences Inc
2024/05/10	05:07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RNA	Avidity Biosciences Inc